| |
Treatment group (n = 24)
|
Control group (n = 22)
|
|---|
|
Measure
|
Baseline
|
Mid
|
After
|
Baseline
|
Mid
|
After
|
|---|
|
MADRS-S
|
24.04 (7.46)
|
13.38 (5.80)
|
10.25 (7.56)
|
20.77 (7.46)
|
21.09 (6.67)
|
19.09 (7.98)
|
|
PSWQ
|
61.88 (11.21)
|
56.21 (13.93)
|
52.67 (12.25)
|
57.95 (10.29)
|
56.91 (10.54)
|
54.68 (11.47)
|
|
GAD-Q-IV
|
10.01 (2.20)
|
7.75 (3.88)
|
7.07 (3.02)
|
9.92 (2.24)
|
9.07 (2.88)
|
9.22 (3.38)
|
|
PSQI
|
10.58 (3.92)
|
6.88 (4.05)
|
5.71 (3.32)
|
9.73 (3.49)
|
9.18 (3.78)
|
8.68 (4.08)
|
|
DERS
|
99.67 (20.18)
|
85.63 (22.55)
|
83.04 (22.86)
|
97.64 (20.33)
|
98.86 (21.88)
|
97.64 (21.43)
|
|
MAAS
|
2.98 (0.65)
|
3.37 (0.79)
|
3.64 (1.06)
|
3.64 (1.06)
|
3.45 (0.72)
|
3.35 (0.81)
|
|
EDN
|
31.59 (15.43)
|
45.48 (15.43)
|
44.05 (16.25)
| | | |
- Note. PSWQ Penn State Worry Questionnaire, GAD-Q-IV Dimensional scoring from the Generalized Anxiety Disorder Questionnaire, MADRS-S Montgomery-Asberg Depression Rating Scale, PSQI Pittsburgh Sleep Quality Index, DERS Dysfunctional Emotional Regulation Scale – Total mean score, MAAS Mindful Attention and Awareness Scale, EDN = Experienced deviation from normal state scale; Baseline = Before treatment; Mid = 4 weeks in treatment; After = Post-treatment
